Subcutaneous Sarilumab in Patients With Rheumatoid Arthritis who Previously Received Subcutaneous Sarilumab or Intravenous Tocilizumab: An Open‐Label Extension of a Randomized Clin...

by Paul Emery, Hubert vanHoogstraten, Karthinathan Thangavelu, Erin Mangan, Gregory St John, Patrick Verschueren
Published 2020-11-01

CXCL8 and CCL20 Enhance Osteoclastogenesis via Modulation of Cytokine Production by Human Primary Osteoblasts.

by Janak L Pathak, Astrid D Bakker, Patrick Verschueren, Willem F Lems, Frank P Luyten, Jenneke Klein-Nulend, Nathalie Bravenboer
Published 2015-01-01

Prevalence and associated factors of subclinical atherosclerosis in rheumatoid arthritis at the university hospital of Kinshasa

by Christophe Mulumba, Pierrot Lebughe, Jean-Marie Mbuyi-Muamba, Jean-Robert Makulo, François Lepira, Jean Mukaya, Rene Westhovens, Patrick Verschueren, Jean-Jacques Malemba
Published 2019-09-01

The ideal mHealth-application for rheumatoid arthritis: qualitative findings from stakeholder focus groups

by Michaël Doumen, René Westhovens, Sofia Pazmino, Delphine Bertrand, Veerle Stouten, Claudia Neys, Nelly Creten, Els Van Laeken, Patrick Verschueren, Diederik De Cock
Published 2021-08-01

One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor well-being after 1 year of treatment

by René Westhovens, An De Groef, Kristien Van der Elst, Philip Moons, Diederik De Cock, Sofia Pazmino, Veerle Stouten, Johan Joly, Patrick Verschueren, Johanna Vriezekolk
Published 2020-05-01

From ELISA to Immunosorbent Tandem Mass Spectrometry Proteoform Analysis: The Example of CXCL8/Interleukin-8

by Mieke Metzemaekers, Sara Abouelasrar Salama, Jennifer Vandooren, Anneleen Mortier, Rik Janssens, Sofie Vandendriessche, Eva Ganseman, Erik Martens, Mieke Gouwy, Barbara Neerinckx, Patrick Verschueren, Lien De Somer, Carine Wouters, Sofie Struyf, Ghislain Opdenakker, Jo Van Damme, Paul Proost
Published 2021-03-01